Depot Disulfiram for AIDS and ARC

Completed · Not applicable

Conditions studied: HIV Infections

In brief

To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

Key facts

Study ID

NCT00002065

Run by

St. Vincent's Medical Center

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.
• Also patient must be:
• Able to understand the study.
• Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
• Ambulatory and able to maintain an independent life outside the hospital.
• Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
• Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
• Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
• History of alcohol abuse.

Where it is running

• Saint Vincent's Med Ctr — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.